Recently, Ms. Dang Lei’s abstract “Osteoblastic PLEKHO1 contributes to joint inflammation in Rheumatoid Arthritis” has been selected as plenary oral presentation at the 39^th KCR Annual Scientific Meeting and the 13^th International Symposium. In addition, Ms. Ren Qing’s abstract “A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low cardiovascular risk to reverse established osteoporosis in ovariectomized rats” has been selected as plenary poster presentation at the 39^th KCR Annual Scientific Meeting and the 13^th International Symposium. Furthermore, after a strict review, the works from Ms. Dang Lei and Ms. Ren Qing have been highly valued and selected to receive the Travel Grant Award on May 18th, 2019 at the Seoul in Korea.